Bologa, C., Allu, T. K., Olah, M., Kappler, M. A., & Oprea, T. I. (2005). Descriptor collision and confusion: Toward the design of descriptors to mask chemical structures. Journal of Computer-Aided Molecular Design, 19(9-10), 625-635. Retrieved from www.scopus.com

Eguchi, Y. (2005). Chemogenomics. Folia Pharmacologica Japonica, 125(6), 365-371. Retrieved from www.scopus.com

Girke, T., Cheng, L. -., & Raikhel, N. (2005). ChemMine. A compound mining database for chemical genomics. Plant Physiology, 138(2), 573-577. Retrieved from www.scopus.com

Haggarty, S. J. (2005). The principle of complementarity: Chemical versus biological space. Current Opinion in Chemical Biology, 9(3), 296-303. Retrieved from www.scopus.com

Hodder, P. (2005). Building a uHTS laboratory. communications from the frontier. Drug Discovery World, 7(1), 31-42. Retrieved from www.scopus.com

Hopkins, A., Lanfear, J., Lipinski, C., & Beeley, L. (2005). Chemical tools for indications discovery Retrieved from www.scopus.com

Kaiser, D., Zdrazil, B., & Ecker, G. F. (2005). Similarity-based descriptors (SIBAR) – A tool for safe exchange of chemical information? Journal of Computer-Aided Molecular Design, 19(9-10), 687-692. Retrieved from www.scopus.com

Lengauer, C., Diaz Jr., L. A., & Saha, S. (2005). Cancer drug discovery through collaboration. Nature Reviews Drug Discovery, 4(5), 375-380. Retrieved from www.scopus.com

O’Connor, K. A., & Roth, B. L. (2005). Finding new tricks for old drugs: An efficient route for public-sector drug discovery. Nature Reviews Drug Discovery, 4(12), 1005-1014. Retrieved from www.scopus.com

Shang, S., & Tan, D. S. (2005). Advancing chemistry and biology through diversity-oriented synthesis of natural product-like libraries. Current Opinion in Chemical Biology, 9(3), 248-258. Retrieved from www.scopus.com

Webb, T. R. (2005). Current directions in the evolution of compound libraries. Current Opinion in Drug Discovery and Development, 8(3), 303-308. Retrieved from www.scopus.com

Workman, P. (2005). Genomics and the second golden era of cancer drug development. Molecular BioSystems, 1(1), 17-26. Retrieved from www.scopus.com